BP000156-CYT-425: Recombinant Human Interleukin 33 (IL-33) Protein
Source: E. coli-derived.
Purity: > 95% by SDS-PAGE and RP-HPLC.BP000153-CYT-371: Recombinant Mouse Interleukin-3 (IL3) Protein
Source: E. coli-derived.
The ED50 as determined by the dose-dependant stimulation of murine M-NFS-60 cells is < 0.05 ng/ml, corresponding to a Specific Activity of 20,000,000 IU/mg.
Purity: > 97% by SDS-PAGE and RP-HPLC.BP000153-CYT-210: Recombinant Human Interleukin-3 (IL3) Protein
Source: E. coli-derived.
The ED50 as determined by the dose-dependant stimulation of TF-1 cells is < 0.1 ng/ml, corresponding to a Specific Activity of 10,000,000 IU/mg.
Purity: > 98% by SDS-PAGE and RP-HPLC.BP000153-CYT-156: Recombinant Rhesus Macaque Interleukin-3 (IL3) Protein
Source: E. coli-derived.
The ED50 as determined by the dose-dependant stimulation of the proliferation of human TF-1 cells is less than 0.1 ng/ml, corresponding to a Specific Activity of 10,000,000 IU/mg.
Purity: > 97.0% by SDS-PAGE.BP000153-CYT-096: Recombinant Human Interleukin-3 (IL3) Protein, HEK
Source: HEK-derived.
The activity was determined by the dose dependent stimulation of the proliferation of human TF-1 cells (human erythroleukemic indicator cell line) and is typically 0.5-2 ug/ml.
Purity: > 90% as obsereved by SDS-PAGE.BP002450-CYT-105: Recombinant Human Interleukin-28B (IL-28B) Protein
Source: HEK-derived.
The specific activity was determined by the dose dependent protection of the cytopathic effect on A549 cells (human lung adenocarcinoma epithelial cell line) that were challenged with encephalomyocarditis (EMC) virus and is typically 0.1-1 ng/ml.
Purity: > 95% as obsereved by SDS-PAGE.BP000148-CYT-701: Recombinant Mouse Interleukin-22 (IL-22) Protein, Pegylated
Source: E. coli-derived.
The ED50 as determined by STAT3 phosphorylation assay in HepG cells. The activity in vitro was found to be ~ 10% compared to the non-pegylated mouse IL22.
Purity: > 98% by SDS-PAGE and RP-HPLC.BP000148-CYT-328: Recombinant Human Interleukin-22 (IL-22) Protein
Source: E. coli-derived.
The Biological Activity was determined by the ability to activiate STAT following receptor ligand interaction.
Purity: > 97% by SDS-PAGE and RP-HPLC.BP000148-CYT-539: Recombinant Mouse Interleukin-22 (IL-22) Protein
Source: E. coli-derived.
The ED50 as determined by its ability to induce IL-10 secretion in Colo205 cells is less than 0.5 ng/ml, corresponding to a Specific Activity of 2 MIU/mg.
Purity: > 97% by SDS-PAGE and RP-HPLC.BP000144-CYT-152: Recombinant Rat Interleukin-1 Receptor Antagonist Protein (IL-1RA)
Source: E. coli-derived.
Fully biologically active when compared to standard. Measured by its ability to inhibit IL1-dependent proliferation in D10.G4.1 mouse helper T cells. The ED50 for this effect is typically 30-150 ng/ml (corresponding to a specific activity of 6,667-33,334 units/mg ) in the presence of 50 pg/ml of rrIL1.
Purity: > 95.0% by SDS-PAGE.